Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2017 1
2019 1
2020 7
2021 3
2022 3
2023 4
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
MYB/MYBL1::QKI fusion-positive diffuse glioma.
Suh YY, Lee K, Shim YM, Phi JH, Park CK, Kim SK, Choi SH, Yun H, Park SH. Suh YY, et al. J Neuropathol Exp Neurol. 2023 Feb 21;82(3):250-260. doi: 10.1093/jnen/nlac123. J Neuropathol Exp Neurol. 2023. PMID: 36592415 Free PMC article. Review.
In Reply to Onal et al.
Nicholls L, Chapman E, Khoo V, Suh YE, van As N. Nicholls L, et al. Among authors: suh ye. Clin Oncol (R Coll Radiol). 2022 Apr;34(4):e173. doi: 10.1016/j.clon.2022.01.009. Epub 2022 Jan 31. Clin Oncol (R Coll Radiol). 2022. PMID: 35093250 No abstract available.
4D-bioprinted silk hydrogels for tissue engineering.
Kim SH, Seo YB, Yeon YK, Lee YJ, Park HS, Sultan MT, Lee JM, Lee JS, Lee OJ, Hong H, Lee H, Ajiteru O, Suh YJ, Song SH, Lee KH, Park CH. Kim SH, et al. Biomaterials. 2020 Nov;260:120281. doi: 10.1016/j.biomaterials.2020.120281. Epub 2020 Aug 12. Biomaterials. 2020. PMID: 32858503
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial.
Yasar B, Suh YE, Chapman E, Nicholls L, Henderson D, Jones C, Morrison K, Wells E, Henderson J, Meehan C, Sohaib A, Taylor H, Tree A, van As N. Yasar B, et al. Among authors: suh ye. Int J Radiat Oncol Biol Phys. 2024 Sep 1;120(1):49-58. doi: 10.1016/j.ijrobp.2024.03.009. Epub 2024 Mar 16. Int J Radiat Oncol Biol Phys. 2024. PMID: 38499253 Free article. Clinical Trial.
Weekly ultra-hypofractionated radiotherapy in localised prostate cancer.
Sundahl N, Brand D, Parker C, Dearnaley D, Tree A, Pathmanathan A, Suh YE, Van As N, Eeles R, Khoo V, Huddart R, Murray J. Sundahl N, et al. Among authors: suh ye. Clin Transl Radiat Oncol. 2024 May 26;47:100800. doi: 10.1016/j.ctro.2024.100800. eCollection 2024 Jul. Clin Transl Radiat Oncol. 2024. PMID: 38872938 Free PMC article.
Patterns of recurrence after prostate bed radiotherapy.
Brand DH, Parker JI, Dearnaley DP, Eeles R, Huddart R, Khoo V, Murray J, Suh YE, Tree AC, van As N, Parker C. Brand DH, et al. Among authors: suh ye. Radiother Oncol. 2019 Dec;141:174-180. doi: 10.1016/j.radonc.2019.09.007. Epub 2019 Sep 25. Radiother Oncol. 2019. PMID: 31563410
Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP Trial.
Patel P, Dreibe S, Attard G, Cole A, Diez P, Frew J, Guevara J, Levine D, McDonald F, Mullassery V, Murray J, Parker C, Palaniappan N, Pathmanathan A, Reid A, Suh YE, Syndikus I, Tirona A, Tran A, Tunariu N, van As NJ, Wylie J, Tree AC. Patel P, et al. Among authors: suh ye. Int J Radiat Oncol Biol Phys. 2025 Mar 9:S0360-3016(25)00225-1. doi: 10.1016/j.ijrobp.2025.02.046. Online ahead of print. Int J Radiat Oncol Biol Phys. 2025. PMID: 40068778 Free article.
26 results